Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
Search
 
My Lists

Principia Biopharma  (Stock symbol: PRNB ) Acquired by Sanofi (2020 $ 3,360,000,000 )

220E Grand Avenue
South San Francisco, CA 94080
USA
650-416-7700
Website Company Summary Management Team
Management

President/COO/Operations: Ann C. Neale (4/30/2018) ; Stefani Wolff (1/31/2016)
Technology: Ken A. Brameld (2/28/2011)
Business Development: Roy Hardiman
Board

Outside board: (May no longer be on the board) Alan B. Colowick (Sofinnova Investments) Simeon George (SR One Partner)
Former outside board: Nassim Usman (Catalyst Biosciences CEO) Philippe Chambon (New Leaf Venture Partners Managing Director) Peter Thompson (OrbiMed Venture Partner)
Former advisory board: Michael Dybbs (New Leaf Venture Partners Principal) Jack Taunton (University of California, San Francisco Associate Professor)
Company

Business description: Principia Biopharma is a clinical-stage biopharmaceutical company focused on bringing transformative therapies to patients with serious immune-mediated diseases by changing the way small molecules are developed. Our mission is to make best-in-class medicines to address unmet medical needs by changing the way small molecule drugs are designed. We are a late-stage biopharmaceutical company developing next-generation therapies — immuno-modulators — that have the potential to transform the treatment of underserved patients who have immune-mediated diseases. We design novel therapies using our proprietary and unique Tailored Covalency® platform. We have developed both reversible covalent and irreversible covalent small molecule drugs that bind very specifically to targets in the body that are central to immune disorders.
Capital

Rounds: 5
Recent Fundings: Dec 2014   Apr 2014
Capital raised: 127.8M
Last Round: 25.0M
Ownership: Acquired by Sanofi (2020 $ 3,360,000,000 ) Ipo Filing
Stock Symbol: PRNB

Last Tweets


 

Last Mentions


Overview
Record updated: Aug 2020
Sector: Medical
Year Founded: 2010
Headcount: 51-75 as of Oct 2018
Rounds: 5
Recent Fundings: Dec 2014   Apr 2014
Capital Raised: 127.8M
Last Round: 25.0M
Ownership: Acquired by Sanofi (2020 $ 3,360,000,000 ) Ipo Filing
Stock Symbol: PRNB